NCT05371275 2022-11-07
CDK6COV
biotx.ai GmbH
Phase 2 Withdrawn
Clinical Trials
4 trialsNCT04220476 2020-09-21
CIMER
Weill Medical College of Cornell University
Phase 2 Withdrawn
NCT03377101 2018-08-14
Fulvestrant and Palbociclib With or Without Copanlisib in Treating Patients With Hormone Receptor Positive, HER2 Negative, Stage IV Breast Cancer
National Cancer Institute (NCI)
Phase 2 Withdrawn
NCT03123744 2018-06-21
Histology-Independent Study of Palbociclib in Patients With Advanced Cancer
University of California, San Diego
Phase 2 Withdrawn